Palladia® (Toceranib Phosphate) - Targeted Anti-Cancer Therapy for Dogs & Cats

Palladia® (Toceranib Phosphate) is a targeted tyrosine kinase inhibitor (TKI) developed for the treatment of cancer in companion animals. It is FDA-approved for canine mast cell tumors and is increasingly used off-label in cats for various neoplastic and proliferative diseases under veterinary guidance.

By selectively blocking tumor growth signals and inhibiting tumor blood vessel formation, Palladia offers a modern, targeted approach to oncology treatment while minimizing damage to healthy tissues.

This medication is widely used in veterinary oncology clinics worldwide and is valued for its oral administration, targeted mechanism, and proven clinical efficacy.